A recent article, published in Clinical Therapeutics, features 27 cases where real world data (RWD) was used in documents submitted for regulatory approval. The article describes different types of RWD. It also discusses how the regulatory landscape has adapted to consider such data.
“Use of real-world data (RWD) has been gaining attention across the regulatory industry. While the current application of RWD has been limited to specific cases, there is a potential to further explore and develop its application.” Read more here.
(Source: Clarivate, 2021)